Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and WBRT in Brain Metastases
NCT01600742Phase 2Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in brain metastasis (BM), sponsored by National Taiwan University Hospital. Started Aug 2012; status: terminated.
02
Drugs
vorinostat
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT01600742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600742.